Coriolus (Trametes) versicolor mushroom to reduce adverse effects from chemotherapy or radiotherapy in people with colorectal cancer

Author:

Pilkington Karen1,Wieland L Susan2,Teng Lida3,Jin Xin Yan4,Storey Dawn5,Liu Jian Ping4

Affiliation:

1. School of Health and Care Professions; University of Portsmouth; Portsmouth UK

2. Center for Integrative Medicine; University of Maryland School of Medicine; Baltimore Maryland USA

3. Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences; The University of Tokyo; Tokyo Japan

4. Centre for Evidence-Based Chinese Medicine; Beijing University of Chinese Medicine; Beijing China

5. Beatson West of Scotland Cancer Centre, Gartnavel General Hospital; Glasgow UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference156 articles.

1. 【Tumor dormancy therapy】Impact of adjuvant postoperative immunochemotherapy for gastrointestinal cancer;G.I.Research,2004

2. Yamaguchi A Nakasato H Ito K Takaki H Adjuvant immunochemotherapy with Krestin after curative resection of colorectal cancer, 7-year follow-up results in a randomized clinical trial (CIP Study Group) 日本癌治療学会誌 (The Journal of Japan Society for Cancer Therapy) 2001 532

3. A randomized clinical trial on adjuvant immunochemotherapy with protein bound polysaccharide K (PSK) after curative resection of colon cancer: Seven-year follow-up results;Ito;International Journal of Antimicrobial Agents,2001

4. Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer. A randomized controlled trial for 7-year follow-up;Ito;International Journal of Colorectal Disease,2004

5. Ito K Nakazato H Takagi H Saji S Koike A Baba S A randomized clinical trial on adjuvant immunochemotherapy with protein bound polysaccharide K (PSK) after curative resection of colon cancer: seven-year follow-up after surgery [abstract] Proceedings of the American Society of Clinical Oncology 2001 117b, Abstract 2220

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3